We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Richardson - Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)
Paul Richardson, MD
Dana-Farber Cancer Institute
Boston, MA
12.03.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles